Moderna says flu vaccine showed promising results in phase three trial, paving path to approval

[cafead]

via

• Moderna said its experimental mRNA-based flu vaccine generated a stronger immune response against four strains of the virus than a currently available flu vaccine.
• The late-stage trial results cleared the way for a path to approval in the U.S.

article source